Alexandros Papachristofilou1, Anna-Lena Hottinger2, Oliver Weinhold2, Yasar-Kemal Avcu2, Tobias Finazzi2, Tamara Diesch3, Ulrich Schratzenstaller2. 1. Clinic of Radiotherapy and Radiation Oncology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland. alexandros.papachristofilou@usb.ch. 2. Clinic of Radiotherapy and Radiation Oncology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland. 3. Department of Pediatric Oncology and Hematology, University Children's Hospital Basel, Basel, Switzerland.
Abstract
PURPOSE: Whole lung irradiation (WLI) is indicated for subgroups of patients with lung metastases from Wilms' tumor (nephroblastoma). WLI has traditionally been performed with an anterior/posterior field arrangement with poor potential for heart sparing; thus, new techniques are desirable to achieve a lower dose to the heart. MATERIALS AND METHODS: We utilized volumetric modulated arc therapy (VMAT) for WLI with 18 Gy in a patient with metastatic nephroblastoma. The planning results were compared against a three-dimensional (3D) conformal plan. RESULTS: VMAT resulted in adequate target volume coverage with the prescribed dose. Mean heart dose was 10.2 Gy. The dose to organs at risk (OAR) was generally more favorable with VMAT when compared with a 3D-conformal radiotherapy plan. DISCUSSION: WLI with VMAT provides superior sparing of OARs and especially a considerably lower dose to the heart.
PURPOSE: Whole lung irradiation (WLI) is indicated for subgroups of patients with lung metastases from Wilms' tumor (nephroblastoma). WLI has traditionally been performed with an anterior/posterior field arrangement with poor potential for heart sparing; thus, new techniques are desirable to achieve a lower dose to the heart. MATERIALS AND METHODS: We utilized volumetric modulated arc therapy (VMAT) for WLI with 18 Gy in a patient with metastatic nephroblastoma. The planning results were compared against a three-dimensional (3D) conformal plan. RESULTS: VMAT resulted in adequate target volume coverage with the prescribed dose. Mean heart dose was 10.2 Gy. The dose to organs at risk (OAR) was generally more favorable with VMAT when compared with a 3D-conformal radiotherapy plan. DISCUSSION: WLI with VMAT provides superior sparing of OARs and especially a considerably lower dose to the heart.
Authors: Stefanie Corradini; Hendrik Ballhausen; Helmut Weingandt; Philipp Freislederer; Stephan Schönecker; Maximilian Niyazi; Cristoforo Simonetto; Markus Eidemüller; Ute Ganswindt; Claus Belka Journal: Strahlenther Onkol Date: 2017-09-15 Impact factor: 3.621
Authors: Sarah C Darby; Marianne Ewertz; Paul McGale; Anna M Bennet; Ulla Blom-Goldman; Dorthe Brønnum; Candace Correa; David Cutter; Giovanna Gagliardi; Bruna Gigante; Maj-Britt Jensen; Andrew Nisbet; Richard Peto; Kazem Rahimi; Carolyn Taylor; Per Hall Journal: N Engl J Med Date: 2013-03-14 Impact factor: 91.245
Authors: Daniel A Mulrooney; Gregory T Armstrong; Sujuan Huang; Kirsten K Ness; Matthew J Ehrhardt; Vijaya M Joshi; Juan Carlos Plana; Elsayed Z Soliman; Daniel M Green; Deokumar Srivastava; Aimee Santucci; Matthew J Krasin; Leslie L Robison; Melissa M Hudson Journal: Ann Intern Med Date: 2016-01-05 Impact factor: 25.391
Authors: G J D'Angio; A E Evans; N Breslow; B Beckwith; H Bishop; P Feigl; W Goodwin; L L Leape; L F Sinks; W Sutow; M Tefft; J Wolff Journal: Cancer Date: 1976-08 Impact factor: 6.860
Authors: F Pein; O Sakiroglu; M Dahan; J Lebidois; P Merlet; A Shamsaldin; E Villain; F de Vathaire; D Sidi; O Hartmann Journal: Br J Cancer Date: 2004-07-05 Impact factor: 7.640
Authors: Ruben Del Castillo; David Martinez; Gustavo J Sarria; Luis Pinillos; Bertha Garcia; Luis Castillo; Alicia Carhuactocto; Frank A Giordano; Gustavo R Sarria Journal: Strahlenther Onkol Date: 2020-08-20 Impact factor: 3.621